ACTAVIS LABS UT INC: Generic drug approval for CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE

ACTAVIS LABS UT INC: Generic drug approval for CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE. Dated 90 days ago, it serves as a historical benchmark. Score 45/100. As of 2026-11-05, from openFDA device PMA and Drugs@FDA endpoints (U.S. Food and Drug Administration).

Data as of · Compiled by Zalwin from openFDA device PMA and Drugs@FDA endpoints (U.S. Food and Drug Administration)

Free preview: all 7 published fields of this record are shown below. Locked: 499 related FdaApprovalPulse records and the 4-column CSV export.

FieldValue
SponsorACTAVIS LABS UT INC
ProductCLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE
Generic / ingredientBENZOYL PEROXIDE, CLINDAMYCIN PHOSPHATE
ApprovalGeneric drug approval (ANDA)
ApplicationANDA208757
Decided2026-08-07
Panel / classGEL, TOPICAL
Peer records CSV (500 records) 🔒 Click to unlock →
CRM-ready export with official source URLs 🔒 Click to unlock →

View the official record

Markdown version

Watch ACTAVIS LABS UT INC

Free email alert. Alert me when this company gets a new filing, lien, permit, contract or expiry in this feed. One confirmation email; unsubscribe any time.

Free for 1 company. More companies from $9/mo (25), $49/mo (500 + CSV), $199/mo (500 + CSV + API). Cancel any time from the link in every email.

Free first: a 10-record sample of records

See the real columns before you buy. One confirmation email, nothing else unless you opt in.

Unlock ACTAVIS LABS UT + 500 peer records (CSV)

Instant CSV download · Card, Apple Pay, Google Pay or Link via Stripe · No account required
CSV columns: Sponsor · Product · Approval · Decided · official source URL

  • Source agency: openFDA device PMA and Drugs@FDA endpoints (U.S. Food and Drug Administration)
  • Record date: 2026-08-07
  • Data refreshed: 2026-11-05
  • Refunds on request within 14 days

Search all records free →

Top FdaApprovalPulse records: Instylla, Inc. · Ventana Medical Systems, Inc. (Roche Tissue Diagnostics) · Cerenovus, Inc. · Advanced Medical Solutions Limited · Lenstec, Inc. · Browse all by state and category →

LIVE PUBLIC DATA Source: openFDA device PMA and Drugs@FDA endpoints (U.S. Food and Drug Administration) · Last refreshed: Thu, 05 Nov 2026 08:47:15 GMT

Is this your business? Add a "Listed on Zalwin" badge to your site

Paste this snippet into your website. It links to this public record; nothing is tracked on your site.

Listed on Zalwin badge preview

Search, filter and export more FdaApprovalPulse records

Run instant live search with these filters Download free sample CSV

✓ Read-only, live public data · Key and unlock right after payment · Card, Apple Pay, Google Pay or Link via Stripe · Refunds on request within 14 days

45 / 100 Score

  • A generic launch.

What is the FdaApprovalPulse record for ACTAVIS LABS UT INC?

The FDA approved CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE (ANDA208757) for ACTAVIS LABS UT INC on 2026-08-07: generic drug approval (ANDA).

How does ACTAVIS LABS UT INC compare to other FdaApprovalPulse records?

It is 90 days old; check the official source for later updates before acting.

ACTAVIS LABS UT INC vs. top 3 peers

OrganizationRecord date
ACTAVIS LABS UT INC2026-08-07
ALEMBIC2026-10-28
NEURORX2026-10-28
ALEMBIC2026-10-26

Related records

FdaApprovalPulse: Generic drug approval (ANDA)

How to monitor ACTAVIS LABS UT INC and peer generic drug approval (anda) records

Get new FdaApprovalPulse records like ACTAVIS LABS UT INC by email (free, weekly)

We email one confirmation link now; the weekly digest starts only after you confirm. One-click unsubscribe in every email.

Double opt-in: nothing is sent until you click the confirmation link. One-click unsubscribe.

See this week's digest

Get new approvals in your categories

FdaApprovalPulse emails new device and drug approvals matching your approval types.

See plans

✓ Read-only, live public data · Key and unlock right after payment · Card, Apple Pay, Google Pay or Link via Stripe · Refunds on request within 14 days

From openFDA (PMA and Drugs@FDA). openFDA can lag FDA decisions by days to weeks. Drug supplement types follow the FDA submission class (labeling and REMS, manufacturing/CMC, efficacy, other). Company and product level only. Verify on FDA databases before relying on an approval.

Often used together